Newbury Pharmaceuticals AB (publ) reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported sales was SEK 11.19 million compared to SEK 0.258 million a year ago. Net loss was SEK 3.52 million compared to SEK 5.74 million a year ago.